Valuation: EMVision Medical Devices Ltd

Market Cap 14Cr 9.55Cr 8.52Cr 7.87Cr 7.14Cr 13Cr 906.13Cr 95Cr 38Cr 474.75Cr 36Cr 35Cr 1.5TCr P/E 2027 *
-12.9x
P/E 2028 * -11.2x
Enterprise Value 14Cr 9.55Cr 8.52Cr 7.87Cr 7.14Cr 13Cr 906.13Cr 95Cr 38Cr 474.75Cr 36Cr 35Cr 1.5TCr EV / Sales 2027 *
27.1x
EV / Sales 2028 * 16x
Free-Float
66.31%
Yield 2027 *
-
Yield 2028 * -
1 day-4.26%
1 week-9.32%
Current month-8.18%
1 month-16.09%
3 months-10.15%
6 months-19.56%
Current year-17.98%
1 week 1.46
Extreme 1.455
1.61
1 month 1.46
Extreme 1.455
1.75
Current year 1.46
Extreme 1.455
1.96
1 year 1.46
Extreme 1.455
1.96
3 years 1.45
Extreme 1.45
2.72
5 years 1.13
Extreme 1.13
2.98
10 years 0.28
Extreme 0.28
4.2
Manager TitleAgeSince
Chief Executive Officer - 01/07/2023
Director of Finance/CFO - 01/02/2026
Chief Tech/Sci/R&D Officer - 01/07/2023
Director TitleAgeSince
Chairman - -
Director/Board Member - -
Director/Board Member - 01/07/2018
Date Insider Type Main position Quantity % Market Cap. Importance
23/04/26 Buy

Director

10,000 0.0108%
02/01/26 Expiration

Chairman

3,00,000 0.3228%
18/11/25 Free

Director

2,00,000 0.2176%
Change 5-day change 1-year change 3-year change Capi.($)
-4.26%-9.32%-21.51%-0.68% 9.55Cr
-0.40%-2.34%+17.82%+45.91% 25TCr
+0.33%+0.64%+3.49%+12.96% 16TCr
+1.90%+6.00%-17.96%+65.92% 16TCr
-0.70%+2.93%-55.38%-8.86% 6.62TCr
+0.15%+4.09%+10.82%+65.55% 5.23TCr
+0.24%+0.99%-15.19%-10.88% 5.22TCr
-1.13%+2.85%+16.39%+28.99% 5.13TCr
-0.47%+0.06%+17.37%+58.29% 4.88TCr
-0.42%+3.83%+27.55%+77.45% 4.46TCr
Average -0.48%+1.10%-1.66%+33.47% 8.84TCr
Weighted average by Cap. +0.14%+1.50%+1.37%+38.41%

Financials

2027 *2028 *
Net sales 50L 35.17L 31.4L 29.01L 26.29L 49.19L 33Cr 3.49Cr 1.38Cr 17Cr 1.32Cr 1.29Cr 55Cr 85L 59.78L 53.39L 49.32L 44.69L 83.62L 57Cr 5.93Cr 2.35Cr 30Cr 2.24Cr 2.2Cr 94Cr
Net income -1.2Cr -84.4L -75.37L -69.63L -63.1L -1.18Cr -80Cr -8.38Cr -3.32Cr -42Cr -3.17Cr -3.1Cr -132.34Cr -1.45Cr -1.02Cr -91.07L -84.13L -76.24L -1.43Cr -97Cr -10Cr -4.01Cr -51Cr -3.83Cr -3.75Cr -159.92Cr
Net Debt - -
Projected Income Statement - Annual - EMVision Medical Devices Ltd
Logo EMVision Medical Devices Ltd
EMVision Medical Devices Limited is an Australian medical device company. The Company is focused on the development and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. The Company’s primary focus is portable and non-invasive brain scanners, including a bedside device (emu) and an ultra-light weight pre-hospital device (First Responder). Its first indication is in stroke care. Its product pipeline includes portable and non-invasive brain scanners, including a bedside device (emu) and a light weight first responder pre-hospital device. Its First Responder Brain Scanner device is an ultra-light weight device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients regardless of location. The emu Brain Scanner device detects clinically significant changes, at the bedside, when time matters.
Employees
-
Date Price Change Volume
23/26/23 A$1.460 -4.26% 57,232
22/26/22 A$1.525 -3.48% 28,537
21/26/21 A$1.580 +0.64% 26,668
20/26/20 A$1.570 +0.32% 23,683
19/26/19 A$1.565 -2.80% 28,361
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.460AUD
Average target price
3.150AUD
Spread / Average Target
+115.75%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - EMVision Medical Devices Ltd